U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Magadoo Corporation Co., Ltd. - 538124 - 02/07/2018
  1. Warning Letters

CLOSEOUT LETTER

Magadoo Corporation Co., Ltd. MARCS-CMS 538124 —

Recipient:
Magadoo Corporation Co., Ltd.

United States

Issuing Office:

United States

 

   

Black HHS-Blue FDA Logo

 

5001 Campus Drive
College Park, MD 20740 
 
 

February 7, 2018

Mr. Jaren Srichanil
Magadoo Corporation Co., LTD
201 Rangsit-Nakornnayok Co., LTD
201 Rangsit-Nakornnayok 33 Road
T.Prachathipat
Thanyaburi, Pathum Thani, 122130
Thailand

Dear Mr. Srichanil:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter #538124 dated October 6, 2017. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/

Robyn R. Jones
Food Adulteration Assessment Branch
Division of Enforcement
Office of Compliance

Back to Top